ID

15179

Description

International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IB (Study Protocol IB with PEG-L-ASP). Clinical Trial Number: NCT01117441.

Mots-clés

Versions (1)
  1. 21/05/2016 21/05/2016 -
Téléchargé le

21 mai 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC-ND 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Protocol IB-ASP+ AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441

Anglais

Protocol IB-ASP+ AIEOP-BFM ALL 2009 NCT01117441

1 Formulaires  
Patient Information
Description

Patient Information

Alias
UMLS CUI-1
C1955348
Stud.-Nr. (Pat.-ID)
Description

Patient ID

Type de données

text

Alias
UMLS CUI [1]
C2348585
Patient date of birth
Description

Patient birthday

Type de données

date

Alias
UMLS CUI [1]
C0421451
Body weight
Description

Weight

Type de données

float

Unités de mesure
  • kg
Alias
UMLS CUI [1]
C0005910
kg
Body height
Description

Height

Type de données

float

Unités de mesure
  • cm
Alias
UMLS CUI [1]
C0005890
cm
Body surface
Description

Body surface

Type de données

float

Unités de mesure
  • mˆ2
Alias
UMLS CUI [1]
C0005902
mˆ2
Chemotherapy Regimen
Description

Chemotherapy Regimen

Alias
UMLS CUI-1
C0392920
Dexamethasone administration form
Description

Dexamethasone: administration form

Type de données

text

Alias
UMLS CUI [1,1]
C0011777
UMLS CUI [1,2]
C0013153
Dexamethasone dosage 10 mg/mˆ2/d
Description

Dexamethasone: dosage

Type de données

float

Unités de mesure
  • mg
Alias
UMLS CUI [1,1]
C0011777
UMLS CUI [1,2]
C0178602
mg
Dexamethasone Date of administration
Description

Dexamethasone: date of administration

Type de données

date

Alias
UMLS CUI [1,1]
C0011777
UMLS CUI [1,2]
C2584899
VCR administration form i.v.
Description

VCR: administration form

Type de données

boolean

Alias
UMLS CUI [1,1]
C0042679
UMLS CUI [1,2]
C1522726
VCR dosage 1,5 mg/mˆ2/ED (max. 2 mg/ED)
Description

VCR: dosage

Type de données

float

Unités de mesure
  • mg
Alias
UMLS CUI [1,1]
C0042679
UMLS CUI [1,2]
C0178602
mg
VCR Date of administration
Description

VCR: date of administration

Type de données

date

Alias
UMLS CUI [1,1]
C0042679
UMLS CUI [1,2]
C2584899
Doxorubicin administration form p.i. (1h)
Description

DOX: administration form

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013089
UMLS CUI [1,2]
C1827465
Doxorubicin dosage 30 mg/mˆ2/ED
Description

DOX: dosage

Type de données

float

Unités de mesure
  • mg
Alias
UMLS CUI [1,1]
C0013089
UMLS CUI [1,2]
C0178602
mg
Doxorubicin Date of administration
Description

DOX: date of administration

Type de données

date

Alias
UMLS CUI [1,1]
C0013089
UMLS CUI [1,2]
C2584899
MTX administration form i.th
Description

MTX: administration form

Type de données

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0677897
MTX dosage (Age-dependent: 1 - < 2 y/o: 8 mg 2 - < 3y/o: 10 mg >= 3 y/o: 12 mg
Description

MTX: dosage

Type de données

float

Unités de mesure
  • mg
Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0178602
mg
MTX Date of administration (while MTX infusion)
Description

MTX: date of administration

Type de données

date

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C2584899
If initial CNS status CNS3, MTX dose (i.th., on day 1 and 18): Date of administration
Description

MTX and CNS status: date of administration

Type de données

date

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0449389
UMLS CUI [1,3]
C2584899
PEG-L-ASP administration form p.i. (2h)
Description

PEG-L-ASP: administration form

Type de données

boolean

Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C1827465
PEG-L-ASP dosage 2500 E/mˆ2/ED (ONCASPAR: 3750 E/ED)
Description

PEG-L-ASP: dosage

Type de données

float

Unités de mesure
  • E
Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C0178602
E
PEG-L-ASP (Next PEG-L-ASP dose: 14 days after dose of day 22)) Date of administration
Description

PEG-L-ASP: date of administration

Type de données

date

Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C2584899
PEG-L-ASP discontinuation
Description

PEG-L-ASP discontinuation

Alias
UMLS CUI-1
C0071568
UMLS CUI-2
C0457454
Discontinuation of PEG-L-ASP therapy in Protocol IIA-ASP+?
Description

PEG-L-ASP discontinuation

Type de données

boolean

Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C0457454
If discontinuation of PEG-L-ASP therapy, specify: Reason for discontinuation:
Description

Reason for discontinuation of PEG-L-ASP therapy

Type de données

text

Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C0457454
UMLS CUI [1,3]
C0392360
If discontinuation of PEG-L-ASP therapy, specify: Reason for discontinuation: If other medical or non-medical reason, specify:
Description

Reason for discontinuation of PEG-L-ASP therapy: specification

Type de données

text

Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C0457454
UMLS CUI [1,3]
C0392360
UMLS CUI [1,4]
C2348235
If discontinuation of PEG-L-ASP therapy, specify: PEG-L-ASP: date of last administration
Description

PEG-L-ASP: date of last administration

Type de données

text

Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C2584899
UMLS CUI [1,3]
C1517741
Change to Erwinase?
Description

Change to Erwinase

Type de données

boolean

Alias
UMLS CUI [1,1]
C0580105
UMLS CUI [1,2]
C0591457
If change to Erwinase, specify: Erwinase: date of first administration
Description

Erwinase: date of first administration

Type de données

date

Alias
UMLS CUI [1,1]
C0591457
UMLS CUI [1,2]
C2584899
UMLS CUI [1,3]
C0205435
If change to Erwinase, specify: Erwinase: date of last administration
Description

Erwinase: date of last administration

Type de données

date

Alias
UMLS CUI [1,1]
C0591457
UMLS CUI [1,2]
C2584899
UMLS CUI [1,3]
C1517741
If change to Erwinase, specify: Numbers of Erwinase doses
Description

Numbers of Erwinase doses

Type de données

float

Alias
UMLS CUI [1,1]
C0591457
UMLS CUI [1,2]
C0237753
If change to Erwinase, specify: Erwinase dose
Description

Erwinase dose

Type de données

float

Unités de mesure
  • E
Alias
UMLS CUI [1,1]
C0591457
UMLS CUI [1,2]
C3174092
E
Hospitalization
Description

Hospitalization

Alias
UMLS CUI-1
C0019993
Number of Nights in Hospital (Day 1 until start of Protocol IIB-ASP+)
Description

Hospital nights

Type de données

float

Unités de mesure
  • nights
Alias
UMLS CUI [1]
C0420496
nights
Identification and Signature
Description

Identification and Signature

Alias
UMLS CUI-1
C0205396
UMLS CUI-3
C1519316
Date and signature of the doctor who calculated and created chemotherapy regimen
Description

Chemotherapy creator: signature

Type de données

text

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1707531
UMLS CUI [2]
C1519316
Date and signature of the person who administered chemotherapy
Description

Chemotherapy administration: signature

Type de données

text

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1533734
UMLS CUI [2]
C1519316
Retour au début de la page

Similar models

Protocol IB-ASP+ AIEOP-BFM ALL 2009 NCT01117441

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Patient Information
C1955348 (UMLS CUI-1)
Patient ID
Item
Stud.-Nr. (Pat.-ID)
text
C2348585 (UMLS CUI [1])
Patient birthday
Item
Patient date of birth
date
C0421451 (UMLS CUI [1])
Weight
Item
Body weight
float
C0005910 (UMLS CUI [1])
Height
Item
Body height
float
C0005890 (UMLS CUI [1])
Body surface
Item
Body surface
float
C0005902 (UMLS CUI [1])
Item Group
Chemotherapy Regimen
C0392920 (UMLS CUI-1)
Dexamethasone: administration form
Item
Dexamethasone administration form
text
C0011777 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
Dexamethasone: dosage
Item
Dexamethasone dosage 10 mg/mˆ2/d
float
C0011777 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Dexamethasone: date of administration
Item
Dexamethasone Date of administration
date
C0011777 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
VCR: administration form
Item
VCR administration form i.v.
boolean
C0042679 (UMLS CUI [1,1])
C1522726 (UMLS CUI [1,2])
VCR: dosage
Item
VCR dosage 1,5 mg/mˆ2/ED (max. 2 mg/ED)
float
C0042679 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
VCR: date of administration
Item
VCR Date of administration
date
C0042679 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
DOX: administration form
Item
Doxorubicin administration form p.i. (1h)
boolean
C0013089 (UMLS CUI [1,1])
C1827465 (UMLS CUI [1,2])
DOX: dosage
Item
Doxorubicin dosage 30 mg/mˆ2/ED
float
C0013089 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
DOX: date of administration
Item
Doxorubicin Date of administration
date
C0013089 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
MTX: administration form
Item
MTX administration form i.th
boolean
C0025677 (UMLS CUI [1,1])
C0677897 (UMLS CUI [1,2])
MTX: dosage
Item
MTX dosage (Age-dependent: 1 - < 2 y/o: 8 mg 2 - < 3y/o: 10 mg >= 3 y/o: 12 mg
float
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
MTX: date of administration
Item
MTX Date of administration (while MTX infusion)
date
C0025677 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
MTX and CNS status: date of administration
Item
If initial CNS status CNS3, MTX dose (i.th., on day 1 and 18): Date of administration
date
C0025677 (UMLS CUI [1,1])
C0449389 (UMLS CUI [1,2])
C2584899 (UMLS CUI [1,3])
PEG-L-ASP: administration form
Item
PEG-L-ASP administration form p.i. (2h)
boolean
C0071568 (UMLS CUI [1,1])
C1827465 (UMLS CUI [1,2])
PEG-L-ASP: dosage
Item
PEG-L-ASP dosage 2500 E/mˆ2/ED (ONCASPAR: 3750 E/ED)
float
C0071568 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
PEG-L-ASP: date of administration
Item
PEG-L-ASP (Next PEG-L-ASP dose: 14 days after dose of day 22)) Date of administration
date
C0071568 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
Item Group
PEG-L-ASP discontinuation
C0071568 (UMLS CUI-1)
C0457454 (UMLS CUI-2)
PEG-L-ASP discontinuation
Item
Discontinuation of PEG-L-ASP therapy in Protocol IIA-ASP+?
boolean
C0071568 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
Item
If discontinuation of PEG-L-ASP therapy, specify: Reason for discontinuation:
text
C0071568 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
Reason for discontinuation of PEG-L-ASP therapy
Code List
If discontinuation of PEG-L-ASP therapy, specify: Reason for discontinuation:
CL Item
allergic reaction to PEG-L-ASP (allergic reaction to PEG-L-ASP)
CL Item
DVT or SVT (DVT or SVT)
CL Item
Pancreatitis (Pancreatitis)
CL Item
Insulin-dependent hyperglycaemia (Insulin-dependent hyperglycaemia)
CL Item
other medical reason (other medical reason)
CL Item
other non-medical reason (other non-medical reason)
Reason for discontinuation of PEG-L-ASP therapy: specification
Item
If discontinuation of PEG-L-ASP therapy, specify: Reason for discontinuation: If other medical or non-medical reason, specify:
text
C0071568 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
Item
If discontinuation of PEG-L-ASP therapy, specify: PEG-L-ASP: date of last administration
text
C0071568 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,3])
PEG-L-ASP: date of last administration
Code List
If discontinuation of PEG-L-ASP therapy, specify: PEG-L-ASP: date of last administration
CL Item
Protocol Day 8 (Protocol Day 8)
CL Item
Protocol Day 22 (Protocol Day 22)
Change to Erwinase
Item
Change to Erwinase?
boolean
C0580105 (UMLS CUI [1,1])
C0591457 (UMLS CUI [1,2])
Erwinase: date of first administration
Item
If change to Erwinase, specify: Erwinase: date of first administration
date
C0591457 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
Erwinase: date of last administration
Item
If change to Erwinase, specify: Erwinase: date of last administration
date
C0591457 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,3])
Numbers of Erwinase doses
Item
If change to Erwinase, specify: Numbers of Erwinase doses
float
C0591457 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Erwinase dose
Item
If change to Erwinase, specify: Erwinase dose
float
C0591457 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
Item Group
Hospitalization
C0019993 (UMLS CUI-1)
Hospital nights
Item
Number of Nights in Hospital (Day 1 until start of Protocol IIB-ASP+)
float
C0420496 (UMLS CUI [1])
Item Group
Identification and Signature
C0205396 (UMLS CUI-1)
C1519316 (UMLS CUI-3)
Chemotherapy creator: signature
Item
Date and signature of the doctor who calculated and created chemotherapy regimen
text
C0392920 (UMLS CUI [1,1])
C1707531 (UMLS CUI [1,2])
C1519316 (UMLS CUI [2])
Chemotherapy administration: signature
Item
Date and signature of the person who administered chemotherapy
text
C0392920 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
C1519316 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial